Correlation Between Biotechnology Ultrasector and Virtus Emerging

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Virtus Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Virtus Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Virtus Emerging Markets, you can compare the effects of market volatilities on Biotechnology Ultrasector and Virtus Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Virtus Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Virtus Emerging.

Diversification Opportunities for Biotechnology Ultrasector and Virtus Emerging

0.68

Correlation Coefficient

Biotechnology Ultrasector  Virtus Emerging

Poor diversification

The 3 months correlation between Biotechnology and VIRTUS is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Virtus Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virtus Emerging Markets and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Virtus Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virtus Emerging Markets has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Virtus Emerging go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Virtus Emerging

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 3.28 times more return on investment than Virtus Emerging. However, Biotechnology Ultrasector is 3.28 times more volatile than Virtus Emerging Markets. It trades about 0.02 of its potential returns per unit of risk. Virtus Emerging Markets is currently generating about -0.02 per unit of risk. If you would invest  5,801  in Biotechnology Ultrasector Profund on February 24, 2024 and sell it today you would earn a total of  191.00  from holding Biotechnology Ultrasector Profund or generate 3.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.6%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Virtus Emerging Markets

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Virtus Emerging Markets

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virtus Emerging Markets has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Virtus Emerging is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Virtus Emerging

The main advantage of trading using opposite Biotechnology Ultrasector and Virtus Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Virtus Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus Emerging will offset losses from the drop in Virtus Emerging's long position.

The idea behind Biotechnology Ultrasector Profund and Virtus Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.